Company / Revenue
IQVIA Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$16.3B
FY2025
5-year range
$11.1B / $16.3B
FY2021-FY2025
Trend
+5.9%
vs FY2024
Sector context
#21 of 156
Health Care
What the data says
IQVIA's revenue of $16.3B is higher than 87% of companies in the Health Care sector (FY2025). Revenue has increased for 7 consecutive years, from $6.8B in FY2018 to $16.3B in FY2025.
Based on SEC 10-K filings.
$16.3B in FY2025 with a 5-year CAGR of +9.4%. Top quartile in the Health Care sector.
Improved from $15.0B to $16.3B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +12.8%
- 5-Year CAGR
- +9.4%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 156This company $16.3B Sector average $19.0B
▼
-14.2% below sector average
Key checks
Key Insights
- IQVIA's revenue has grown for 7 consecutive years.
- 5-year CAGR of +9.4%, indicating consistent growth.
- In FY2025, revenue increased 5.9% year-over-year.
- Ranks #21 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 20.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.3B | +5.9% |
| FY2024 | $15.4B | +2.8% |
| FY2023 | $15.0B | +31.9% |
| FY2022 | $11.4B | +2.4% |
| FY2021 | $11.1B | +6.5% |
| FY2020 | $10.4B | +7.3% |
| FY2019 | $9.7B | +42.4% |
| FY2018 | $6.8B | -30.0% |
| FY2017 | $9.7B | +41.6% |
| FY2016 | $6.9B | +19.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026